E
Aion Therapeutic Inc. ANTCF
OTC PK
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

10/31/2023 07/31/2023 04/30/2023 01/31/2023 10/31/2022
Net Income -187.80K -191.10K -534.10K -160.00K -481.20K
Total Depreciation and Amortization -- -- 100.00 4.30K 4.40K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 23.50K 23.90K 474.80K -70.00K 407.10K
Change in Net Operating Assets 61.40K 62.50K 171.20K 136.80K 75.70K
Cash from Operations -102.90K -104.70K 111.90K -88.90K 6.00K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- 0.00 100.30K --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -98.00K -99.70K -- -- --
Cash from Investing -98.00K -99.70K 0.00 100.30K --
Total Debt Issued -- -- 1.00K 18.40K 79.20K
Total Debt Repaid -- -- -100.00 -141.70K -6.40K
Issuance of Common Stock 271.30K 271.30K 0.00 0.00 100.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 199.70K 203.30K 600.00 -91.50K 129.90K
Foreign Exchange rate Adjustments 1.30K 1.30K -112.30K 70.00K -138.50K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 200.00 200.00 200.00 -10.00K -2.60K
Weiss Ratings